Surajit Sinha

机构：Center for Cancer Research · ORCID：0000-0002-7204-2248

发表论文 68 篇 · 总被引 261 次 · h-index 5

代表论文

A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion (2025 · JCI Insight · 被引 2)
Additional file 1 of Study protocol: targeted delivery of interleukin-12 in combination with hepatic artery infusion pump therapy for patients with adrenocortical carcinoma liver metastases (2026 · Figshare)
Additional file 1 of Study protocol: targeted delivery of interleukin-12 in combination with hepatic artery infusion pump therapy for patients with adrenocortical carcinoma liver metastases (2026 · Figshare)
Data from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity (2025)
Figure S11 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity (2025)
Figure S1 from Antibody-Mediated Inhibition of HLA/LILR Interactions Breaks Innate Immune Tolerance and Induces Antitumor Immunity (2025)